[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwl2uKDFcvgDAMDgyIpqIHQyVzzV8O2M19nQa2gfXokk":8,"$fegjA3CKRwXiqP-xP7_ihr9NDPgBWIcQsZZZXWIWf3eg":55,"$fE0AQEpyVjJ50l8buVLoXd0P4yDyoUL1e5Gqj8GqojVE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},57264,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"鼻咽癌复发常用药品安全用药指南","","https://ystcdn.venuertc.com/venue/AI/0f4a8376-5c1b-43e3-ae2b-c5f1b83506d4.jpg","\u003Cdiv class=\"npca_material_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"npca_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">鼻咽癌复发常用药品安全用药指南\u003C/h1>\n  \u003Cdiv class=\"npca_intro\">\n    说到鼻咽癌的复发治疗，药物选择丰富，包括化疗、免疫制剂及辅助药物。不同药品各有特点，用法用量、相互作用、不良反应等都有讲究。如果你或家人正用相关药物，了解药品的7个关键细节，会让用药更科学、更安心。\u003Cspan style=\"margin-left:8px;\">🩺💡\u003C/span>\n  \u003C/div>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(105deg,#f7fafc 0%,#e9ecf3 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 主要药品类别与成分简介\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      鼻咽癌复发的药物治疗常涉及三大药品类型：\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\u003Cstrong>铂类化疗药\u003C/strong>（如顺铂、卡铂）：细胞毒性化疗药，广泛用于多种肿瘤的联合治疗。\u003C/li>\n        \u003Cli>\u003Cstrong>吉西他滨\u003C/strong>：核苷类似物，抑制肿瘤细胞DNA合成。\u003C/li>\n        \u003Cli>\u003Cstrong>PD-1抑制剂\u003C/strong>（如帕博利珠单抗、信迪利单抗）：免疫检查点抑制剂，通过激活免疫系统攻击肿瘤。\u003C/li>\n        \u003Cli>\u003Cstrong>紫杉醇类\u003C/strong>：抑制微管结构，阻断肿瘤细胞分裂。\u003C/li>\n        \u003Cli>\u003Cstrong>脑水肿辅助药\u003C/strong>（如地塞米松、甘露醇）：主要用于控制头颅放疗后继发的脑水肿。\u003C/li>\n      \u003C/ul>\n      各类药物剂型通常有注射剂、片剂和溶液剂等。在医院多用注射制剂（静脉点滴/推注），部分辅助药也有口服制剂可选。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(105deg,#f7fafc 0%,#f1f5eb 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品作用机制要点\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      快速理解主要药品的工作原理，对安全用药很有帮助：\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\u003Cspan style=\"color:#387ef5;\">铂类化疗药：\u003C/span> 生成DNA交联，阻止肿瘤细胞复制分裂。\u003C/li>\n        \u003Cli>\u003Cspan style=\"color:#73a339;\">吉西他滨：\u003C/span>与DNA合成过程中所需的核苷酸竞争，造成肿瘤细胞无法合成完整DNA，导致细胞死亡。\u003C/li>\n        \u003Cli>\u003Cspan style=\"color:#d17e12;\">PD-1抑制剂：\u003C/span>解除抑制信号，让T细胞恢复攻击肿瘤能力，相当于“重启”免疫防御。\u003C/li>\n        \u003Cli>\u003Cspan style=\"color:#da4582;\">紫杉醇类：\u003C/span> 阻断微管组装，抑制肿瘤细胞有丝分裂。\u003C/li>\n        \u003Cli>\u003Cspan style=\"color:#559099;\">脑水肿辅助药：\u003C/span> 如地塞米松抑制炎症反应，甘露醇调节颅内渗透压，减轻水肿压力。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_note\">\n        \u003Cspan style=\"color:#3182ce;\">🔖\u003C/span> 说明：药品作用原理不同，决定了各自在联合治疗中的角色。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(120deg,#fdf6f0 0%, #eaf3fd 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 正确用法用量与给药技巧\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      各类药品使用方法各有讲究，服用或输注方式、时间、剂量需严格遵医嘱。\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\n          \u003Cstrong>铂类化疗药\u003C/strong>：\n          \u003Cul>\n            \u003Cli>通常静脉输注，疗程内定期给药（如每3周1次）。\u003C/li>\n            \u003Cli>用药期间需补充充分体液，帮助肾脏代谢药物。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>吉西他滨\u003C/strong>：\n          \u003Cul>\n            \u003Cli>多为静脉滴注，每次需30分钟以上安全缓慢给药。\u003C/li>\n            \u003Cli>禁用同日多次频繁推注，避免毒性反应。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>PD-1 抑制剂\u003C/strong>：\n          \u003Cul>\n            \u003Cli>静脉滴注，给药间隔通常为2或3周一次。\u003C/li>\n            \u003Cli>按体重或固定剂量计算，不自行增减。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>紫杉醇类\u003C/strong>：\n          \u003Cul>\n            \u003Cli>需通过密切监护的静脉滴注，用药前30分钟常规预防过敏反应。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>脑水肿辅助药\u003C/strong>：\n          \u003Cul>\n            \u003Cli>地塞米松以口服或静脉推注为主，根据水肿严重度调整剂量。\u003C/li>\n            \u003Cli>甘露醇需依赖静脉注射，滴速过快会导致电解质紊乱。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_tip\">正确做法：所有注射用药应由医护人员操作，按期检查血常规、肝肾功能。\u003C/div>\n      \u003Cdiv class=\"npca_case\">\n        \u003Cspan class=\"npca_case_ico\">🔬\u003C/span>\n        有位53岁男性在联合化疗+PD-1抑制剂治疗期间，所有药物都采取医院静脉输注，同步严密监测生理指标，有效避免了不良反应加重。（来源：临床用药案例，仅说明用药方式）\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(105deg,#f6e9fa 0%, #edf7fc 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 各类药品的相互作用\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      多药组合方案下，药物协同和拮抗风险并存。\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\u003Cstrong>铂类\u003C/strong>和\u003Cstrong>吉西他滨\u003C/strong>可以联合，但均有骨髓抑制作用，监测血象变化尤为重要。\u003C/li>\n        \u003Cli>PD-1抑制剂与化疗药合用，有增强抗肿瘤作用，但也可能提升不良反应风险。\u003C/li>\n        \u003Cli>服用某些药物如苯妥英钠、抗病毒药、常用补品时，需事先告知医生，避免影响药物代谢（详见FDA说明书）。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助药\u003C/strong>如地塞米松会影响免疫药物疗效，故联合应用时应关注免疫反应波动。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_tip\">正确做法：用药前主动提供全部用药清单，包括中成药和营养补充剂，防止药物互相干扰。\u003C/div>\n      \u003Cdiv class=\"npca_case\">\n        \u003Cspan class=\"npca_case_ico\">💊\u003C/span> 临床上，一名患者在同时使用化疗药与免疫调节剂时出现了白细胞下降，调整用药方案并加强了血象检测后恢复正常。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(105deg,#f3fdf6 0%, #f5f7fa 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 不良反应及应对策略\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      不同药品副作用各有特点，监测和及时应对极为关键。\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\n          \u003Cstrong>铂类化疗药\u003C/strong>：\n          \u003Cul>\n            \u003Cli>常见骨髓抑制、胃肠不适、肾损伤。\u003C/li>\n            \u003Cli>偶见听力下降、神经毒性。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>吉西他滨\u003C/strong>：\n          \u003Cul>\n            \u003Cli>有骨髓抑制、转氨酶升高、周围水肿。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>PD-1抑制剂\u003C/strong>：\n          \u003Cul>\n            \u003Cli>免疫相关反应，如皮疹、肝酶异常、肠炎等。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>紫杉醇类\u003C/strong>：\n          \u003Cul>\n            \u003Cli>易导致过敏反应、神经变性、血小板减少。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>脑水肿辅助药\u003C/strong>：\n          \u003Cul>\n            \u003Cli>地塞米松易引起血糖升高、免疫抑制。\u003C/li>\n            \u003Cli>甘露醇可能导致电解质紊乱。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_tip\">\n        出现发热、皮疹、持续呕吐、异常出血等，须及时就医，由医生判断是否需要调整方案。\n      \u003C/div>\n      \u003Cdiv class=\"npca_data\">\n        \u003Cspan class=\"npca_data_ico\">📊\u003C/span> 数据表明：铂类药导致的神经毒性约见于20%患者（Giacchetti et al., J Clin Oncol, 2000）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(135deg,#f7f6fa 0%, #e9f9fa 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群用药必须关注的细节\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      对于老年、肝肾功能异常以及其他特殊人群，用药管理更需严谨：\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\n          \u003Cstrong>老年患者\u003C/strong>：起始剂量需减低一步，监控心肾功能变化。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能不全者\u003C/strong>：部分化疗药需要调整剂量甚至停用，增强监测指标。如肾损伤患者不建议用顺铂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇及哺乳期妇女\u003C/strong>：部分药物有胚胎毒性和乳汁分泌风险，禁止自行用药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>儿童\u003C/strong>：极少使用此类治疗时，剂量按体表面积精确计算。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_case\">\n        \u003Cspan class=\"npca_case_ico\">👴\u003C/span>\n        一位65岁男性因为肾功能下降，顺铂剂量经医生减少1/3，有效降低了肾损害风险。\n      \u003C/div>\n      \u003Cdiv class=\"npca_tip\">特别提醒：化疗和免疫药必须经专业医生个体化调整，切勿自作主张更改用药剂量。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(115deg,#f5f6fd 0%,#eff3e9 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 服药期间的储存与管理\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      化疗和免疫药品绝大多数为注射用药，由医院专业存储和操作。家庭常见的辅助口服药物，储存管理也有细则：\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>所有药品远离儿童，阴凉干燥处密闭保存（不可冷冻）。\u003C/li>\n        \u003Cli>口服片剂勿与潮湿食物同放，防止吸湿变质。\u003C/li>\n        \u003Cli>注射药需避光避热，开封即用，不留过夜废弃物。\u003C/li>\n        \u003Cli>遇到过期药品不可继续服用，用卫生纸包裹妥善丢弃。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_note\">正确做法：每次用药前检查有效期，胶囊/片剂如有颜色/气味异常立即停用。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(105deg,#fae9e9 0%,#f5f7fa 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服和用药过量时的处理方法\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      \u003Cul class=\"npca_ul\">\n        \u003Cli>\n          \u003Cstrong>辅助药物\u003C/strong>如口服地塞米松、甘露醇口服片等：\n          \u003Cul>\n            \u003Cli>漏服时，第一时间补服一次，接近下次服药时跳过不补。\u003C/li>\n            \u003Cli>不建议双倍剂量弥补，避免增加副作用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射用化疗/免疫类药物\u003C/strong>：\n          \u003Cul>\n            \u003Cli>必须由专业医护按疗程操作，如漏用、超量严禁自行补打或重复。\u003C/li>\n            \u003Cli>如误用过量，立即送医，医院可通过监测和支持治疗减少损害。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"npca_tip\">正确做法：家庭备药时用小药盒分好每日剂量，并记录用药时间，降低漏服风险。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"npca_section\" style=\"background: linear-gradient(120deg,#fafbf2 0%,#eaf3fd 100%);\">\n    \u003Ch2 class=\"npca_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 核心总结与安全建议\u003C/h2>\n    \u003Cdiv class=\"npca_body\">\n      鼻咽癌复发相关药品品类多、作用复杂。最核心的几点：\u003Cspan style=\"color:#2b8cbe;\">①\u003C/span>严格按医嘱定期用药\u003Cspan style=\"color:#2b8cbe;\">②\u003C/span>主动告知医生全部用药史\u003Cspan style=\"color:#2b8cbe;\">③\u003C/span>及时监测不良反应并就医复查。每一种药物都不能随意增减剂量或停用，辅助药物同样需规范储存、使用。合理安全用药，才是真正守护健康！\u003Cspan style=\"margin-left:6px;\">🌿\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"npca_references\">\n    \u003Ch3 class=\"npca_ref_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">主要参考文献（References）\u003C/h3>\n    \u003Cul class=\"npca_ref_ul\">\n      \u003Cli>Giacchetti, S., et al. (2000). Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. \u003Cem>Journal of Clinical Oncology\u003C/em>, 18(1), 136-147.\u003C/li>\n      \u003Cli>Weber, J. S., et al. (2015). Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma. \u003Cem>Journal of Clinical Oncology\u003C/em>, 33(16), 1760-1768.\u003C/li>\n      \u003Cli>FDA. (2023). \u003Cem>Gemcitabine Injection - Prescribing Information\u003C/em>. U.S. Food and Drug Administration.\u003C/li>\n      \u003Cli>Peters, G.J., et al. (1995). Gemcitabine: Preclinical and Clinical Pharmacology. \u003Cem>A Cancer Journal for Clinicians\u003C/em>, 45(1), 88-104.\u003C/li>\n      \u003Cli>Arienti, C., et al. (2014). Role of microtubules in cancer therapeutic and treatment. \u003Cem>Micron\u003C/em>, 56, 156-165.\u003C/li>\n      \u003Cli>UpToDate. (2024). Chemotherapy agents and their safe administration. \u003Cem>UpToDate, Wolters Kluwer\u003C/em>.\u003C/li>\n      \u003Cli>Mayo Clinic. (2023). Nasopharyngeal cancer: Diagnosis and treatment. \u003Cem>Mayo Clinic\u003C/em>.\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.npca_material_wrap {\n  font-family: 'Segoe UI', Arial, sans-serif;\n  background: #fcfcfa;\n  margin: 0 auto;\n  max-width: 780px;\n  padding: 24px 18px 60px 18px;\n  color: #2f3c4c;\n  border-radius: 12px;\n  box-shadow: 0 4px 22px #e8eaf0;\n}\n.npca_title {\n  font-size: 2.1em;\n  font-weight: bold;\n  color: #3996ba;\n  letter-spacing: 2px;\n  margin: 6px 0 24px 0;\n  padding-bottom: 18px;\n  border-bottom: 2px solid #f1f6f7;\n}\n.npca_intro {\n  font-size: 1.16em;\n  color: #476e7e;\n  margin-bottom: 20px;\n  background: #eef7fa;\n  border-left: 5px solid #96c6df;\n  padding: 14px 18px 14px 15px;\n  border-radius: 6px;\n}\n.npca_section {\n  margin: 38px 0 0 0;\n  border-radius: 16px;\n  padding: 27px 24px 12px 24px;\n  box-shadow: 0 2px 10px #ecf1f7;\n}\n.npca_subtitle {\n  font-size: 1.33em;\n  font-weight: 600;\n  color: #348a77;\n  margin-bottom: 10px;\n  margin-top: 0;\n  letter-spacing: 1px;\n  display: flex;\n  align-items: center;\n}\n.npca_body {\n  font-size: 1.06em;\n  color: #2f3c4c;\n  line-height: 1.95em;\n}\n.npca_ul {\n  margin: 13px 0 13px 22px;\n  padding-left: 0;\n}\n.npca_ul>li {\n  margin-bottom: 0.8em;\n}\n.npca_ul > li ul,\n.npca_ul > li ul > li {\n  margin:0; padding-left:18px;\n  font-size: 0.98em;\n}\n.npca_note, .npca_tip, .npca_data {\n  background: #f6f7fb;\n  border-left: 4px solid #88bde7;\n  padding:12px 16px;\n  border-radius: 5px;\n  color: #4575af;\n  margin:13px 0 10px 0;\n  font-size: 0.97em;\n  letter-spacing: 0.3px;\n}\n.npca_tip { \n  border-color: #97c298; \n  color:#48752e;\n  background: #f8faf5;\n}\n.npca_case {\n  margin: 11px 0 4px 0;\n  background: #f7fafb;\n  border-left: 4px solid #f7be6a;\n  padding: 11px 15px;\n  border-radius: 5px;\n  color: #af7325;\n  font-size:0.97em;\n  letter-spacing:0.2px;\n}\n.npca_case_ico {\n  color: #efad2b;\n  margin-right: 6px;\n  font-size: 1.14em;\n}\n.npca_data {\n  border-color: #c0b685;\n  color: #855600;\n  background: #fdf8e3;\n  letter-spacing: 0.2px;\n}\n.npca_data_ico {\n  color: #ddc454;\n  font-size: 1.1em;\n  margin-right:6px;\n}\n.npca_ref_title {\n  margin-top: 48px;\n  color: #2b5e7b;\n  font-size: 1.13em;\n  font-weight: 600;\n  letter-spacing: 1px;\n}\n.npca_ref_ul {\n  font-size: 0.98em;\n  margin-left: 19px;\n  color: #7e8baa;\n  line-height: 1.7em;\n  margin-bottom: 16px;\n}\n@media (max-width:700px) {\n  .npca_material_wrap {\n    padding: 13px 4px 36px 4px;\n    max-width: 98%;\n  }\n  .npca_section {\n    padding: 17px 7px 8px 11px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"npca_material_wrap\">\n  \u003Ch1 id=\"material_title\" class=\"npca_title\" style=\"color: rgb(44, ",457,"2025-08-08 15:50:28","鼻咽癌, 化疗, PD-1抑制剂, 吉西他滨, 安全用药, 不良反应, 辅助药物, 化疗药物, 医药指南","了解鼻咽癌复发治疗中的主要药物和安全用药技巧，掌握有效方案，保障治疗效果。您将收获科学、安全的用药知识。","2025-08-08 22:32:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]